SCHEMBL1634722

SCHEMBL1634722

CS(=O)(=O)N1CCC(Oc2cccc3cnc(Nc4ccc(S(N)(=O)=O)cc4)nc23)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 3/20 0.54
JAK1 P23458 3/20 0.54
TYK2 P29597 3/20 0.54
JAK3 P52333 3/20 0.54
TNIK Q9UKE5 1/20 0.49
STK4 Q13043 4/20 0.47
TTK P33981 3/20 0.44
CDK2 P24941 5/20 0.43
CDK1 P06493 4/20 0.43
CDK9 P50750 3/20 0.43
CCNE1 P24864 3/20 0.43
IKBKB O14920 2/20 0.43
MCHR1 Q99705 1/20 0.43
CHUK O15111 1/20 0.43
SYK P43405 1/20 0.42
CCNT1 O60563 2/20 0.41
CCNB1 P14635 2/20 0.41
CDK7 P50613 1/20 0.41
CCNH P51946 1/20 0.41
CCNB2 O95067 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1633530 0.91 JAK2 (0.58) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1631022 0.88 JAK2 (0.54) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1632811 0.88 JAK2 (0.54) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1632506 0.88 JAK2 (0.55) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1633462 0.88 JAK2 (0.55) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1632504 0.88 JAK2 (0.55) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1634743 0.87 TNIK (0.55) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1634712 0.87 JAK2 (0.72) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1632315 0.86 JAK2 (0.52) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1633545 0.85 JAK2 (0.65) JAK2JAK1TYK2JAK3TNIK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed